Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme
- PMID: 18561312
- DOI: 10.1002/ijc.23648
Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme
Abstract
Glioblastoma Multiforme (GBM) is almost inevitably a fatal tumor of the brain with most individuals dying within 1 year of diagnosis. It is the most frequent brain tumor in adults. Dose-response studies showed that Cucurbitacin B inhibited 50% growth (ED(50)) of 5 human GBM cell lines in liquid culture at approximately 10(-7) M. Soft-gel assays demonstrated that nearly all of the GBM clonogenic cells were inhibited at 10(-8) M of Cucurbitacin B. FACS analysis found that the compound (10(-7) M, 24 hr) caused G2/M arrest. The GBM cells underwent profound morphologic changes within 15-30 min after exposure to Cucurbitacin B (10(-7) M), rounding up and losing their pseudopodia associated with disruption of actin and microtubules, as observed by immunoflourescence. Cucurbitacin B (10(-7) M) caused prominent multinucleation of the cells after they were pulse-exposed (48 hr) to the drug, washed and cultured in normal medium for an additional 2 days. The drug (10(-7) M, 3-24 hr) increased levels of p-p38, p-JNK and p-JUN in U87 and T98G GBM cell lines as seen by Western blot. Interestingly, alterations in cell morphology caused by Cucurbitacin B (10(-7) M) were blocked by the JNK inhibitor SP600125. In summary, Cucurbitacin B has a prominent anti-proliferative activity on GBM cells; and at least in part, the mode of action is by affecting the cytoskeleton, as well as, the JNK pathway. Clinical trails of this drug should be pursued in GBM.
Copyright 2008 Wiley-Liss, Inc.
Similar articles
-
Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.BMC Complement Altern Med. 2012 Oct 12;12:185. doi: 10.1186/1472-6882-12-185. BMC Complement Altern Med. 2012. PMID: 23062075 Free PMC article.
-
Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.Int J Oncol. 2010 Sep;37(3):737-43. doi: 10.3892/ijo_00000723. Int J Oncol. 2010. PMID: 20664943 Free PMC article.
-
Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM).Oncogene. 2005 Jan 13;24(3):344-54. doi: 10.1038/sj.onc.1208225. Oncogene. 2005. PMID: 15531918
-
Modulation of Calcium Signaling in Glioblastoma Multiforme: A Therapeutic Promise for Natural Products.Mini Rev Med Chem. 2020;20(18):1879-1899. doi: 10.2174/1389557520666200807133659. Mini Rev Med Chem. 2020. PMID: 32767939 Review.
-
An Insight into Emerging Phytocompounds for Glioblastoma Multiforme Therapy.Cardiovasc Hematol Agents Med Chem. 2024;22(3):336-347. doi: 10.2174/0118715257262003231031171910. Cardiovasc Hematol Agents Med Chem. 2024. PMID: 37957904 Review.
Cited by
-
Anti-Proliferative, Cytotoxic and Antioxidant Properties of the Methanolic Extracts of Five Saudi Arabian Flora with Folkloric Medicinal Use: Aizoon canariense, Citrullus colocynthis, Maerua crassifolia, Rhazya stricta and Tribulus macropterus.Plants (Basel). 2021 Sep 30;10(10):2073. doi: 10.3390/plants10102073. Plants (Basel). 2021. PMID: 34685882 Free PMC article.
-
Cucurbitacin E induces cell cycle G2/M phase arrest and apoptosis in triple negative breast cancer.PLoS One. 2014 Jul 29;9(7):e103760. doi: 10.1371/journal.pone.0103760. eCollection 2014. PLoS One. 2014. PMID: 25072848 Free PMC article.
-
Receptor activation and inhibition in cellular response to chemotherapeutic combinational mimicries: the concept of divergent targeting.J Neurooncol. 2010 Dec;100(3):345-61. doi: 10.1007/s11060-010-0196-7. Epub 2010 May 14. J Neurooncol. 2010. PMID: 20467786
-
Recent Advances in the Application of Cucurbitacins as Anticancer Agents.Metabolites. 2023 Oct 14;13(10):1081. doi: 10.3390/metabo13101081. Metabolites. 2023. PMID: 37887406 Free PMC article. Review.
-
The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivo.Cancer Res. 2010 Feb 15;70(4):1356-66. doi: 10.1158/0008-5472.CAN-09-2178. Epub 2010 Feb 2. Cancer Res. 2010. PMID: 20124472 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
